View all services

Mergers & Acquisitions

Pfizer's Upjohn Unit Combined With Mylan to Form Viatris

Pfizer (NYSE: PFE), a multinational pharmaceutical company, completed the spin off of its Upjohn business unit which subsequently combined with Mylan N.V., a European pharmaceutical firm, to form Viatris (Nasdaq: VTRS) in a transaction valued at $12 billion.

Morrow Sodali acted as the information agent for the bidder in this transaction.

Find more information here.

For further inquiries
Contact us
Contact us

Please complete this form to be contacted by a Morrow Sodali representative.